Anaveon announced the appointment of Laetitia Pouzol as its new Chief Scientific Officer, underscoring the company’s focus on immunology. The press release, originating from the United States, signals a strategic leadership shift at the biotechnology firm.

MIT’s Associate Professor Bryan Bryson is uncovering how Myobacterium tuberculosis interacts with our immune systems, in a focus that could reshape TB vaccine strategies. By translating these biological insights into engineering solutions, Bryson hopes to help eliminate a disease that remains a global challenge.